Win-Partners Co., Ltd. logo

Win-Partners Co., Ltd. (3183)

Market Open
10 Aug, 06:00
JPX JPX
¥
1,259. 00
-6
-0.4743%
¥
37.2B Market Cap
- P/E Ratio
216% Div Yield
15,400 Volume
- Eps
¥ 1,265
Previous Close
Add Transaction
Day Range
1,256 1,280
Year Range
1,175 1,527
Want to track 3183 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3183 trading today lower at ¥1,259, a decrease of -0.4743% from yesterday's close, completing a monthly increase of 1.9433% or ¥24. Over the past 12 months, 3183 stock lost -6.3244%.
3183 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Win-Partners Co., Ltd. has completed 4 stock splits, with the recent split occurring on Dec 28, 2016.
The company's stock is traded on one exchange.

3183 Chart

People also search for

Sakata Seed Corporation
¥ 4,385
-0.2275%
MTG Co., Ltd.
¥ 8,180
+2.7638%
As One Corporation
¥ 2,383
+0.063%
Pigeon Corporation
¥ 2,079
-0.1441%
Noevir Holdings Co., Ltd.
¥ 4,815
-0.1037%

Win-Partners Co., Ltd. (3183) FAQ

What is the stock price today?

The current price is ¥1,259.00.

On which exchange is it traded?

Win-Partners Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 3183.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 216%.

What is its market cap?

As of today, the market cap is 37.2B.

Has Win-Partners Co., Ltd. ever had a stock split?

Win-Partners Co., Ltd. had 4 splits and the recent split was on Dec 28, 2016.

Win-Partners Co., Ltd. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Hideumi Akizawa CEO
JPX Exchange
JP3154390003 ISIN
Japan Country
630 Employees
- Last Dividend
28 Dec 2016 Last Split
- IPO Date

Overview

WIN-Partners Co., Ltd. is a Japanese corporation focused on the distribution of medical devices to medical institutions across Japan. Founded in 1973 and based out of Tokyo, Japan, the company operates through its subsidiaries to supply a wide range of specialized medical equipment. Its portfolio caters to various medical needs, including cardiovascular care, diabetes management, and advanced diagnostic imaging. Over the years, WIN-Partners Co., Ltd. has established itself as a key player in the Japanese medical device market, offering innovative solutions and supporting the healthcare industry with cutting-edge technology.

Products and Services

  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Drug-Eluting Stents, and Intravascular Ultrasound (IVUS) Catheters

    These cardiovascular products are designed for interventions in coronary artery disease, supporting the reopening of blocked arteries, delivering medication to prevent restenosis, and providing imaging support for detailed internal views of the vessels.

  • Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy (CRT) Devices, and Ablation Catheters

    These devices cater to patients with heart rhythm disorders, offering solutions to regulate heartbeats, prevent sudden cardiac arrest, and correct heart rhythm abnormalities. Ablation catheters are used in procedures to remove abnormal heart tissues causing arrhythmias.

  • Stent Grafts, Transcatheter Heart Valves, and Mechanical Heart Valves

    Surgical and minimally invasive options for treating vascular and valvular heart diseases, including aneurysms and valve dysfunctions. These devices help to restore normal blood flow and heart function.

  • Peripheral Vascular Stents, Carotid Artery Stents, and Embolic Coils

    These products address conditions affecting the peripheral and cerebral vasculature, offering therapeutic solutions for diseases such as peripheral artery disease (PAD) and cerebral aneurysms, thereby preventing strokes and improving blood flow.

  • Insulin Pumps and Continuous Glucose Monitoring Systems

    Technologies for diabetes management that provide automated insulin delivery and real-time blood glucose monitoring, facilitating the management of blood sugar levels for diabetes patients.

  • Computed Tomography (CT) Equipment

    Advanced imaging devices that allow detailed cross-sectional images of the body, aiding in the diagnosis and treatment of various conditions by providing high-resolution images of the body's internal structures.

Contact Information

Address: Kyobashi Edogrand
Phone: 81 3 3548 0790